Correlation of absolute nil-per-oral status with inferior vena cava collapsibility index and post-spinal hypotension in infra-umbilical surgeries: An observational study Authors: Sanjeeb Pradhan, Habib M. R. Karim, Chinmaya K. Panda, Nandkishore Agrawal Published: 2026 ABSTRACT ABSTRACTBackground and Aims:Prolonged pre-operative fasting is considered as a risk factor for hypovolaemia and spinal anaesthesia-induced hypotension (SAIH). However, physiological compensatory mechanisms may offset fasting-related hypovolaemia. We aimed to examine relationships among absolute nil-per-os (NPO) duration, inferior vena cava collapsibility index (IVCCI), and SAIH in patients under spinal anaesthesia.Methods:This prospective, non-randomised observational study enroled adults scheduled for infra-umbilical surgery. Absolute NPO duration was calculated after adjusting for maintenance intravenous fluids. Pre-operative IVCCI was measured with ultrasonography. SAIH was defined as a >20% reduction in mean blood pressure from baseline. Spearman’s rank correlation, receiver operating characteristic (ROC) analysis, and multivariable logistic regression were performed to assess associations and predictors of SAIH.Results:Data from 51 patients were analysed. IVCCI increased significantly with longer absolute NPO duration (P < 0.001). Absolute NPO duration showed limited ability to discriminate SAIH [area under the ROC curve (AUROC) 0.61, P = 0.17], and IVCCI demonstrated moderate discriminatory ability within this cohort (AUROC 0.70, P = 0.016). In multivariable analysis, IVCCI was the only independent predictor of SAIH [adjusted odds 1.07 per 1% increase, (95% confidence interval: 1.00, 1.15); P = 0.049]. Absolute NPO duration correlated negatively with minimum inferior vena cava diameter (ρ = −0.36, P = 0.009) and positively with IVCCI (ρ = 0.61, P < 0.001).Conclusion:While absolute NPO duration is related to IVCCI, our findings show that only IVCCI independently predicts SAIH. Implementing pre-operative IVCCI assessment might guide individualised fluid optimisation and prevent SAIH, particularly in patients undergoing prolonged pre-operative fasting. INTRODUCTION Pre-operative fasting is routine to reduce the risk of pulmonary aspiration during anaesthesia. Current guidelines allow clear fluids up to 2 h before surgery.[1] However, unnecessary nil-per-os (NPO) (nothing by mouth) status frequently persists, especially in high-volume operative settings.[2] Extended NPO status has been linked to dehydration, post-operative organ dysfunction, and haemodynamic instability, including spinal anaesthesia-induced hypotension (SAIH).[34] SAIH mainly results from sympathetic blockade. This reduces systemic vascular resistance and promotes venous pooling. Various strategies, including intravenous fluid (IVF) pre-loading and co-loading, have been proposed to address this, but outcomes remain inconsistent.[56] Notably, prolonged NPO status does not consistently cause intravascular hypovolaemia, likely due to strong physiological homeostatic mechanisms.[4] Accurate bedside assessment of intravascular volume remains difficult. Invasive haemodynamic monitoring provides detailed physiological information but is limited by cost, technical complexity, and procedural risks. Conventional clinical parameters are poor surrogates for intravascular volume and fluid responsiveness. Inferior vena cava collapsibility index (IVCCI), assessed by ultrasonography even by novices, has been recognised as a simple, non-invasive marker of volume status and fluid responsiveness.[78] Given the lack of prospective data integrating physiologically adjusted fasting exposure with bedside ultrasound assessment, this study primarily aimed to explore associations between absolute NPO duration and its association with SAIH. The secondary objective was to explore the correlations between absolute NPO duration and inferior vena cava (IVC) diameter parameters, IVCCI, and the association between IVCCI and the occurrence of SAIH. METHODS This hypothesis-generating, exploratory, prospective observational study with a non-randomised parallel-group design was conducted at a tertiary care academic hospital between July 2021 and March 2023. Ethical approval was obtained from the institutional ethics committee (Letter No. 1720/IEC-AIIMSRPR/2021), and the study was prospectively registered with the Clinical Trials Registry-India (CTRI/2021/07/034789). The study followed good clinical practice and complied with the Declaration of Helsinki. Adult patients aged 18–65 years, classified as American Society of Anesthesiologists physical status (ASA-PS) I–III, scheduled for infra-umbilical non-vascular surgery under spinal anaesthesia, were enroled for the study. After identifying prospective participants, written and informed consent from the willing participants was obtained. Eligible patients were those scheduled for infra-umbilical non-vascular surgery under spinal anaesthesia (SA). Patients were excluded if they refused participation or had a poor ultrasound window, shock, sepsis, significant cardiac or vascular disease, uncontrolled systemic illness, pregnancy, or conversion to general anaesthesia. Further, if the drug dose for SA used was less than 3 ml, those cases were also excluded post-hoc. Participants were grouped based on absolute NPO duration into ≤4 h, 4–8 h, and >8 h. Participants were enroled through convenience sampling based on the investigator’s availability in the operating theatre. The literature search done at the time of the study’s conception revealed no studies with a similar objective. Therefore, we conducted a pilot study to assess the prevalence of hypotension in our setup. The sample size was calculated for an expected prevalence of 40% (as found in our pilot sample) and hypotension, with 95% confidence, yielding a sample of 6 patients per group for the pilot study. The calculation was performed using https://www.crutzen.net/n.htm, which uses the method of Viechtbauer et al.[9] Further, given non-randomised enrolment, a design effect of 1.4 was added to yield a pilot sample of 9 per group. However, after enroling 30 patients, an interim screening and analysis were conducted, and further enrolment continued to achieve a minimum of 9 patients per group. As the sampling was non-randomised and group allocation was done after fulfilment of eligibility criteria, the allocation could not be fixed at a particular ratio; 31 more patients were enroled (total 61). Absolute NPO duration was calculated after adjusting for maintenance IVF administered during the preceding 2 h, accounting for crystalloid redistribution kinetics.[10] For patients receiving maintenance intravenous crystalloid fluids calculated using the standard “4–2–1” formula (which determines hourly maintenance fluid rates based on body weight: 4 mL/kg for the first 10 kg, 2 mL/kg for the next 10 kg, and 1 mL/kg for each kg above 20 kg), the volume of IVF administered per kilogram of body weight during the preceding 2 h was documented. Given that the intravascular half-life (t½) of crystalloids ranges between 20 and 40 min, an average half-life of 30 min was assumed for the purpose of calculation. Based on published population-level crystalloid kinetics, we estimated that approximately 5% of crystalloids administered more than 2 h prior to assessment would remain in the intravascular compartment; this fraction was considered negligible and therefore excluded from calculations. The intravascular fraction of IVF in the previous 2 h was estimated using an exponential decay model. The sum included: 50% of the volume administered 0–30 min prior, 25% between 30 and 60 min, 12.5% between 60 and 90 min, and 6.25% between 90 and 120 min before assessment. Absolute NPO duration was calculated by subtracting the time of effective maintenance IVF (up to 2 h) from the time since the last oral intake. Patients who received a colloidal bolus or a crystalloid bolus for resuscitation at 20 mL/kg within 30 min prior to assessment were excluded, per pre-established criteria. The interval between IVCCI assessment and SA was recorded, with a maximum allowable time of 15 min. IVCCI was measured immediately before transfer to the operating room. All measurements were performed by an anaesthesiologist experienced in at least 30 prior IVCCI assessments. The patient was made to lie supine on a couch. A subxiphoid view was obtained with a portable ultrasound system (Sonosite Edge II, FUJIFILMTM SonoSite, Inc., Washington, United States) using a curvilinear transducer (2–5 MHz). Once the right atrium was clearly visualised, the transducer was rotated counterclockwise to visualise the IVC as it entered the right atrium. Respiratory variation in IVC diameter was assessed using full-screen M-mode imaging at a standardised location approximately 2 cm caudal to the hepatic vein–IVC junction. After obtaining a stable M-mode tracing, the image was frozen, and the maximum (dIVCmax) and minimum (dIVCmin) IVC diameters during the respiratory cycle were measured using electronic callipers. Next, IVCCI was calculated using the formula: [(dIVCmax – dIVCmin)/dIVCmax] × 100, which has a proven perioperative role.[11] The IVCCI measurement was obtained twice, and the average of the two measurements was used as the study value. Standard SA was administered in the operating theatre without investigator intervention. Haemodynamic parameters were recorded at baseline and at set intervals after SA. SAIH was defined as a ≥20% reduction in mean blood pressure (MBP) from baseline.[12] Patient demographic and clinical characteristics, including age, gender, and baseline, were also recorded. Details of perioperative medications, including vasoactive agents, NPO duration for solids and liquids, time and volume of last oral intake, and IVF administration, were documented. Information regarding the type and dose of intrathecal drugs administered was noted. The incidence of SAIH was also recorded. Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 23 (International Business Machines SPSS Statistics, New York, United States). Data distribution was analysed for normality. Continuous variables were analysed using non-parametric tests, such as the Kruskal–Wallis test, where appropriate, and categorical variables using Chi-square or Fisher’s exact tests. Analysis of variance was used for parametric data. Receiver operating characteristic (ROC) analysis was used to evaluate diagnostic performance, and the area under the ROC (AUROC) is presented. Multivariable logistic regression was performed to identify associated predictors of SAIH. A P-value < 0.05 was considered statistically significant. RESULTS Ten eligible participants got excluded owing to non-agreeable IVC diameter measurements due to poor assessment windows and differences in the SA drug administered. A total of 51 patients entered the intraoperative data collection phase for the primary outcome, and all patients’ data (11 in < 4 h, 10 in 4–8 h, and 30 in > 8 h groups; P < 0.001) were included in the final analysis [Supplementary File S1]. All cases were National Institute for Health and Care Excellence (NICE) grade II surgeries. All patients received 3.2–3.5 mL of 0.5% bupivacaine (heavy) combined with or without fentanyl 20–25 μg, except two (one each < 4 and 4–8 h group), which received 5 μg dexmedetomidine and were excluded. The level of block achieved within 20 min of SA was also similar across the groups (ranging from T8 to T10). Baseline demographic characteristics, American Society of Anesthesiologists Physical Status (ASA-PS) classification system, body mass index, baseline haemodynamic parameters, fluid therapies, and worst haemodynamic parameters were comparable across the three NPO duration groups [Table 1]. Intraoperative haemodynamics at 5, 10, and 15 min, fluid administration at different times, worst systolic blood pressure (BP), diastolic BP, mean arterial pressure, peripheral oxygen saturation (SpO2), and heart rate (HR) were statistically indifferent. The IVFs administered at different times during the surgeries were also similar [Supplementary File S2]. Table 1Comparison of demographic, perioperative, and haemodynamic variables according to absolute NPO duration groupsVariable (Absolute NPO)<4 h (n=11)4–8 h (n=10)>8 h (n=30)Test Statistic P Age (years)37.45±13.3534.10±8.9141.50±16.80H=2.010.365GenderMale: 9 (81.8%); Female: 2 (18.2%)Male: 8 (80%); Female: 2 (20%)Male: 23 (76.7%); Female: 7 (23.3%)χ²=0.140.930Height (cm)165.0±5.92159.4±6.82157.57±4.37H=4.010.134Weight (kg)61.09±8.0858.40±9.1756.63±8.05F=1.190.313BMI (kg/m²)25.99±4.2226.45±4.1125.31±4.20H=0.850.654ASA-PSII: 8 (72.7%); I: 3 (27.3%)II: 7 (70%); I: 3 (30%)II: 22 (73.3%); I: 8 (26.7%)χ²=0.040.979Time since last oral fluid intake (h)3.33 [2.74–3.92]8.40 [7.50–9.30]13.26 [12.70–13.82]F=227.92<0.001*Duration of preoperative IVF (min)133.27 [102.45–164.10]204.00 [167.81–240.19]210.00 [180.00–240.00]H=15.15<0.001*Amount of preoperative IVF (mL)182.73 [126.92–238.54]266.00 [216.53–315.47]350.00 [300.00–397.50]H=20.35<0.001*Absolute NPO duration (min)80.00 [60.00–90.00]399.00 [351.49–446.51]670.60 [634.99–706.21]H=39.20<0.001*Total amount of IVF administered (mL)335.0 [265.2–404.9]325.0 [225.0–360.0]320.0 [240.0–390.0]H=0.530.767Total intravascular volume added (mL)79.22 [61.65–96.79]73.15 [58.14–88.16]75.00 [56.20–91.78]H=0.270.871Intraoperative IVF during induction (mL)87.27 [67.10–107.45]80.00 [62.80–97.20]80.00 [60.00–97.50]H=0.340.842Intraoperative IVF at 30–60 min (mL)86.36 [68.21–104.52]77.50 [60.20–94.80]80.00 [60.00–100.00]H=0.640.726Intraoperative IVF at 60–90 min (mL)83.64 [64.33–102.94]73.50 [58.99–88.01]80.00 [60.00–97.50]H=0.600.739Intraoperative IVF at 90–120 min (mL)81.36 [66.95–95.78]70.00 [52.50–80.00]80.00 [60.00–97.50]H=2.410.299Baseline HR (beats/min)91.00 [77.63–104.37]92.50 [86.50–106.50]87.07 [80.39–93.74]H=2.590.274Baseline MBP (mmHg)97.27±4.6597.60±6.7991.93±3.89F=2.020.144Lowest HR (beats/min)84.91 [70.53–99.29]95.00 [70.50–102.00]73.00 [60.00–99.75]H=1.690.428Lowest MBP (mmHg)69.55±4.9569.10±9.3066.80±7.48F=0.730.487Lowest systolic BP (mmHg)91.09±8.5592.10±8.9287.90±10.51F=0.890.418Lowest diastolic BP (mmHg)58.91 [54.56–63.26]57.00 [50.35–63.65]56.00 [48.50–62.00]H=1.250.534Lowest SpO2 (%)100 [99–100]100 [100–100]99 [99–100]H=4.770.091HypotensionAbsent: 8; Present: 3Absent: 6; Present: 4Absent: 16; Present: 14χ²=1.260.533*Statistically significant (P<0.05). NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SpO2: Peripheral oxygen saturation; BP: Blood pressure; HR: Heart rate; ASA-PS: American Society of Anesthesiologists physical status; BMI: Body mass index Comparison of demographic, perioperative, and haemodynamic variables according to absolute NPO duration groups *Statistically significant (P<0.05). NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SpO2: Peripheral oxygen saturation; BP: Blood pressure; HR: Heart rate; ASA-PS: American Society of Anesthesiologists physical status; BMI: Body mass index Supplementary File S2Comparison of variables and their divisions across absolute NPO duration groups tested using Chi-square (χ²), Analysis of variance (F) and Kruskal-Wallis (H) tests presented as either absolute numbers or mean [interquartile range]Variable<4 h [n=11]4–8 h [n=10]>8 h [n=30]Test statistic P Age (years) in subgroups31-40: 4 (36.36%);31-40: 4 (40%);18-30: 11 (36.67%);χ²=12.140.14518-30: 3 (27.28%);41-50: 3 (30%);61-70: 8 (26.67%);41-50: 2 (18.18%);18-30: 3 (30%)51-60: 5 (16.66%);61-70: 1 (9.9%);31-40: 4 (13.33%);51-60: 1 (9.9%)41-50: 2 (6.67%)Body mass index (kg/m2) subgroups25.0-29.9: 6 (54.54%);25.0-29.9: 7 (70%);25.0-29.9: 14 (46.67%);χ²=4.250.83318.5-22.9: 3 (27.28%);18.5-22.9: 2 (20%);18.5-22.9: 6 (20%);30.0-34.9: 1 (9.9%);23.0-24.9: 1 (10%)30.0-34.9: 5 (16.66%);23.0-24.9: 1 (9.9%)23.0-24.9: 3 (10%);<18.5: 2 (6.67%)Total Intravascular Volume Added (mL)79.22 [61.65–96.79]73.15 [58.14–88.16]75.00 [56.20–91.78]H=0.270.871Systolic BP (mmHg) (Baseline)132.18 [126.83–137.54]132.10 [126.98–137.22]128.00 [118.00–135.50]H=2.260.323Diastolic BP (mmHg) (Baseline)78.36 [73.17–83.55]79.20 [72.45–85.95]78.00 [68.50–81.00]H=1.660.437SpO2 (%) (Baseline)100 [100–100]100 [99.25–100]100 [99–100]H=2.330.311Heart Rate (beats per min) (5 minutes)88.82 [74.55–103.08]95.20 [88.37–102.03]86.10 [79.79–92.41]F=1.100.341MBP (mmHg) (5 minutes)92.36 [87.20–97.53]95.90 [89.52–102.28]89.87 [86.24–93.49]F=1.670.198Systolic BP (mmHg) (5 minutes)126.36 [121.24–131.48]130.40 [125.10–135.70]126.00 [115.50–130.00]H=3.610.164Diastolic BP (mmHg) (5 minutes)75.45 [69.35–81.56]78.40 [71.02–85.78]73.77 [70.26–77.27]F=0.900.411SpO2 (%) (5 minutes)100 [100–100]100 [99.25–100]100 [99–100]H=0.960.619HR (beats per min) (10 minutes)86.73 [72.91–100.54]93.90 [86.69–101.11]85.77 [79.26–92.28]F=0.870.425MBP (mmHg) (10 minutes)93.00 [87.50–94.50]91.50 [84.32–98.68]87.13 [82.74–91.53]H=1.100.578Systolic BP (mmHg) (10 minutes)126.45 [117.75–135.16]126.20 [119.89–132.51]124.00 [103.50–128.00]H=3.330.188Diastolic BP (mmHg) (10 minutes)71.73 [63.96–79.49]73.60 [65.74–81.46]71.50 [67.37–75.63]F=0.140.873SpO2 (%) (10 minutes)100.00 [99.00–100.00]100.00 [99.25–100.00]100.00 [99.00–100.00]H=0.480.786HR (beats per min) (15 minutes)85.73 [71.08–100.37]93.60 [83.44–103.76]84.00 [77.29–90.71]F=1.050.358MBP (mmHg) (15 minutes)86.18 [78.84–93.52]85.80 [75.59–96.01]81.93 [78.27–85.59]F=0.850.435Systolic BP (mmHg) (15 minutes)122.00 [118.50–126.00]118.80 [109.64–127.96]111.70 [107.11–116.29]H=4.950.084Diastolic BP (mmHg) (15 minutes)69.64 [62.04–77.23]70.50 [61.88–79.12]66.00 [60.00–77.50]H=1.570.456SpO2 (%) (15 minutes)100 [100–100]100 [100–100]99 [99–100]H=6.290.043NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SpO2: Peripheral oxyhaemoglobin saturation; BP: Blood pressure; HR: Heart rate; ASA-PS: American Society of Anesthesiologists physical status; NICE: National Institute for Health and Care Excellence; BMI: Body mass index Comparison of variables and their divisions across absolute NPO duration groups tested using Chi-square (χ²), Analysis of variance (F) and Kruskal-Wallis (H) tests presented as either absolute numbers or mean [interquartile range] NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SpO2: Peripheral oxyhaemoglobin saturation; BP: Blood pressure; HR: Heart rate; ASA-PS: American Society of Anesthesiologists physical status; NICE: National Institute for Health and Care Excellence; BMI: Body mass index IVCCI increased progressively with increasing absolute NPO duration, with the highest median values observed in patients fasting for more than 8 h (P < 0.001). The incidence of SAIH also increased numerically with longer fasting duration (27.3%, 40.0%, and 46.7% in ≤4 h, 4–8 h, and >8 h groups, respectively), although this difference was not statistically significant [Figure 1]. Box-and-Whisker and line combination plot for IVCCI and percentage of patients having post-SA hypotension among the absolute NPO duration groups. IVCCI: Inferior vena cava collapsibility index; SA: Spinal anaesthesia ROC analysis showed poor discriminatory ability of absolute NPO duration for predicting SAIH (AUROC 0.61, P = 0.17). In contrast, IVCCI demonstrated moderate discriminatory ability in this cohort, with an AUROC of 0.70 [95% confidence interval (CI): 0.54, 0.86]; P = 0.016 [Figure 2]. ROC curve with AUROC for (a) absolute NPO durations, and (b) for IVCCI. ROC: Receiver operating characteristic; AUROC: Area under ROC; NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index An IVCCI exploratory threshold ≥24% predicted hypotension with a sensitivity of 81% and a specificity of 67%. The diagnostic test performances for predicting SAIH for absolute NPO duration, IVCCI, and IVF administration durations are presented in Table 2. Table 2Diagnostic performance test results for absolute NPO duration, IVCCI, and IVF administeredParameterValue (95% CI)Value (95% CI)Value (95% CI)ParameterNPO durationIVCCIIVF durationCut-off (exploratory threshold) (P)≥540 (0.173)≥24 (0.016)≤180 (0.984)AUROC0.613 (0.457 - 0.77)0.7 (0.541 - 0.859)0.502 (0.335 - 0.67)Sensitivity66.7% (43-85)81.0% (58-95)57.1% (34-78)Specificity53.3% (34-72)66.7% (47-83)60.0% (41-77)PPV50.0% (31-69)63.0% (42-81)50.0% (29-71)NPV69.6% (47-87)83.3% (63-95)66.7% (46-83)Diagnostic Accuracy58.8% (44-72)72.5% (58-84)58.8% (44-72)PLR1.43 (0.88-2.33)2.43 (1.41-4.2)1.43 (0.8-2.54)NLR0.63 (0.31-1.25)0.29 (0.11-0.72)0.71 (0.4-1.27)Diagnostic OR2.29 (0.72-7.27)8.5 (2.25-32.06)2 (0.65-6.2)CI: Confidence interval; PPV: Positive predictive value; NPV: Negative predictive value; PLR: Positive likelihood ratio; NLR: Negative likelihood ratio; OR: Odds ratio; IVF: Intravenous fluid; IVCCI: Inferior vena cava collapsibility index; NPO: Nil-per-os; AUROC: Area under receiver operating characteristic curve Diagnostic performance test results for absolute NPO duration, IVCCI, and IVF administered CI: Confidence interval; PPV: Positive predictive value; NPV: Negative predictive value; PLR: Positive likelihood ratio; NLR: Negative likelihood ratio; OR: Odds ratio; IVF: Intravenous fluid; IVCCI: Inferior vena cava collapsibility index; NPO: Nil-per-os; AUROC: Area under receiver operating characteristic curve A multivariable binary logistic regression analysis was performed to identify associated predictors of SAIH. The dependent variable was the occurrence of SAIH (present vs absent). The following covariates were entered simultaneously into the model based on physiological plausibility and prior literature: IVCCI, % as a continuous variable, absolute NPO duration in min, age in years, baseline MBP (mmHg), and total preoperative IVF volume administered (mL). Model estimation was performed using maximum-likelihood binary logistic regression, which revealed IVCCI as the only predictor of SAIH, with an adjusted odds ratio of 1.07 per 1% increase (95% CI: 1.00, 1.15); P = 0.049. Absolute NPO duration, age, baseline MBP, and preoperative IVF volume were not independently associated with SAIH [Table 3]. Table 3Results of the multivariate logistic regression analysis for variables tested for independent prediction of post-SA hypotensionVariableAdjusted OR95% CI P IVCCI (%)1.07 per 1% increase1.00 – 1.150.049Absolute NPO duration (min)1.000.997 – 1.0030.841Age (years)1.030.99 – 1.070.192Baseline MBP (mmHg)1.020.95 – 1.100.518Total IVF (mL)0.990.99 – 1.000.388NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SA: Spinal anaesthesia Results of the multivariate logistic regression analysis for variables tested for independent prediction of post-SA hypotension NPO: Nil-per-os; IVCCI: Inferior vena cava collapsibility index; MBP: Mean blood pressure; IVF: Intravenous fluids; OR: Odds ratio; CI: Confidence interval; SA: Spinal anaesthesia Absolute NPO duration demonstrated a moderate negative correlation with minimum IVC diameter (Spearman’s ρ = −0.36, P = 0.009) and a strong positive correlation with IVCCI (Spearman’s ρ = 0.61, P < 0.001). No significant correlation was observed between absolute NPO duration and dIVCmax (Spearman’s ρ = −0.09, P = 0.55). There was a progressive reduction in IVC diameter measurements with increasing fasting duration; the predominant changes were in the dIVCmin and IVCCI. The scatter plot with regression lines is presented in Figure 3. Scatter plot with regression line correlation graph of absolute NPO duration and IVC parameters. NPO: Nil-per-os; IVC: Inferior vena cava DISCUSSION The findings show that absolute NPO duration correlates negatively with dIVCmin and positively with IVCCI, but not with dIVCmax. Although prolonged absolute NPO duration is associated with a modestly increased incidence of SAIH, fasting duration alone does not show discriminatory potential to predict this outcome. In contrast, IVCCI emerged as an associated predictor, underscoring its superior utility over fasting duration for assessing SAIH risk. While a longer absolute NPO duration is associated with progressive relative hypovolaemia, fasting duration may primarily reflect temporal exposure rather than a direct physiological measure of preload. In contrast, IVCCI dynamically reflects respiratory variation in venous return and has been shown to correlate with intravascular volume status and predict SAIH.[11] SAIH is a multifactorial event influenced by sympathetic blockade, vascular tone, cardiac reserve, and additional circumstantial factors.[13] Therefore, fasting duration alone lacks specificity as a predictor, whereas IVCCI reflects the cumulative physiological effects at the time of assessment, which explains its better predictive ability in both short- and long-fasting preoperative patients.[14] Physiological compensatory neuro-humoral responses and renal water conservation, which may maintain BP despite reduced preload, likely contribute to the limited predictive value of fasting duration alone.[151617] These findings correspond with previous evidence demonstrating preserved haemodynamic stability in spite of prolonged fasting and with physiological data indicating compensatory redistribution of body water compartments during fasting, rather than overt intravascular depletion.[418] Although fluid preloading has traditionally been employed to prevent SAIH, evidence suggests inconsistent benefit, and excessive fluid administration may predispose susceptible patients to fluid overload and cardiovascular decompensation.[519] Our observations align with prior reports suggesting preserved haemodynamics despite prolonged fasting, while extending these findings by integrating ultrasound-based assessment. The results showed a good correlation between IVCCI and fasting duration, as well as IVCCI and SAIH, but with moderate predictability.[1820] Thus, IVCCI-guided fluid optimisation may allow targeted therapy, avoiding unnecessary IVF administration in prolonged fasted patients.[21] Nevertheless, these findings do not support fasting duration alone as a clinical decision-making tool, especially when patients are on IVFs. Instead, IVCCI may offer a pragmatic bedside adjunct for individualised fluid assessment, pending validation in larger, randomised studies. Our study stands out for a few reasons. It tackles an everyday clinical question in operative practice and uses a physiologically rigorous definition for NPO exposure. Objective ultrasound-based assessment of patients’ intravascular status, rigorous prospective design, and solid statistical analysis plan raise the bar. The study highlights that, in patients who are on IVF maintenance started following 8 h of NPO, IVCCI, rather than the fasting duration itself, actually predicts who will get SAIH. It gives us a practical, evidence-backed alternative to the old habit of guess-based preloading fluids. Our limited literature search identified the hypothesis as an under-researched area as we found only a study by Muller and colleagues, published more than a decade ago.[4] However, recently, Agarwal J et al.[22] explored the association of IVC-related parameters with fasting status and hypotension under general anaesthesia and found poor correlation. The present study has several limitations, including its single-centre design, modest sample size, pilot research framework, post hoc exclusion of significant results, assumption-based NPO, potential single-operator dependency in ultrasound measurements, non-blind operator for IVCCI measurements, and convenience sampling. Although multivariate analysis, diagnostic performance analysis, and Spearman correlation analysis provide an advantage over the robust statistical methods used, a relatively low number of variables were included in the multivariate analysis. Although operator experience was standardised, and IVCCI measurement has shown to be efficient even for novices, inter-rater variability cannot be excluded.[7] The inclusion of emergency cases may have influenced stress responses and haemodynamic outcomes. Infra-umbilical surgeries were included to maintain uniformity and minimise variation in the drug dose used, but this also decreases generalisability. Further, the results may not be generalisable to high-risk populations of ASA-PS class IV or higher. Thus, larger, multicentre studies are needed to confirm these results. CONCLUSION Absolute NPO duration correlated negatively with dIVCmin, positively with IVCCI, and not with dIVCmax. However, it does not independently predict SAIH. Preoperative IVCCI is an associated predictor of SAIH and demonstrated moderate discriminatory ability within this cohort. Incorporating bedside IVCCI assessment into routine preoperative evaluation may support individualised fluid management and enhance haemodynamic stability after SA. Considering the fact that our cohort with NPO > 8 h were on IVF, IVF administration to patients fasting for > 8 h warrants further investigation as a potential mitigator to SAIH. Author contributions SP, HMRK, CKP, NA: Conceptualisation, Methodology, Literature search, Interpretation. SP: Data collection, Draft writing. CKP, NA: Manuscript writing and review. HMRK: Manuscript editing. SP, HMRK, CKP: Guarantors. Presentation at conferences/CMEs and abstract publication None. Study data availability De-identified data may be requested with reasonable justification from the authors (email to the corresponding author) and shall be shared after approval as per the authors’ Institution policy. Disclosure of use of artificial intelligence (AI)-assistive or generative tools No artificial intelligence was used for manuscript preparation except for Grammarly for academic language editing. Declaration of use of permitted tools Not applicable. Supplementary material This article has supplementary material and can be accessed at this link. Supplementary Material at http://links.lww.com/IJOA/A78. Conflicts of interest There are no conflicts of interest. Participant flow diagram. SA: Spinal anaesthesia; NPO: Nil-per-os; GA: General anaesthesia